Skip to main content

MARSHALL WACE, LLP

Position in MDXG — Mimedx Group, Inc.

CIK 1318757 LONDON, X0

Position in MDXG

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$7,351,526
-$1,999,793 QoQ
Shares Held
1,861,146
+34.7% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in MDXG Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. MDXG ranks #77 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MDXG

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,351,526 1,861,146
2025-12-31 $9,351,319 1,381,288
2025-09-30 $999,228 143,156
2025-06-30 $2,316,679 379,162
2024-12-31 $3,354,945 348,747
2024-09-30 $2,059,794 348,527
2024-06-30 $2,070,808 298,818
2024-03-31 $2,276,081 295,595
2023-12-31 $2,907,202 331,494
2023-09-30 $4,071,494 558,504
2023-06-30 $1,537,333 232,577
2023-03-31 $1,099,844 322,535
2020-12-31 $1,366,058 150,447